CSIMarket
 


Arqule Inc  (ARQL)
Other Ticker:  
 

Cumulative Arqule Inc's Quick Ratio for Trailing Twelve Months Period

ARQL's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth



ARQL Quick Ratio for Trailing Twelve Months Period

(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Current Liabilities Growth 33.47 % 67.48 % 74.85 % 49.76 % 38.43 %
Y / Y Cash & cash equivalent Growth 24.99 % 288.76 % 115.05 % 107.26 % 262.94 %
Quick Ratio for Trailing Twelve Months Period 8.56 8.69 6.96 6.81 6.32
Total Ranking # 285 # 282 # # #
Seq. Current Liabilities Growth 6.96 % -3.44 % -1.07 % 30.63 % 34.21 %
Seq. Cash & cash equivalent Growth -30.1 % 94.23 % -7.37 % -0.62 % 117.43 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to rise in Current Liabilities in the III. Quarter to $15 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 8.56 below Arqule Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 70 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Arqule Inc. While Quick Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 282 to 285.

What is Quick Ratio?
Learn more about ARQL
Quick Ratio ARQL in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 71
Sector # 128
S&P 500 # 274


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
8.51 4.11 3.12
(Jun 30 2019)   (March 31, 2015)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2019, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Geron Corp  23.10 
Ideaya Biosciences Inc   22.78 
Glycomimetics Inc  21.65 
Crinetics Pharmaceuticals Inc   20.99 
Provention Bio Inc   19.78 
Kura Oncology Inc   19.21 
Aravive Inc   19.19 
Ra Pharmaceuticals Inc   18.14 
Prothena Corp Plc  18.05 
Fulcrum Therapeutics Inc   17.68 
Karuna Therapeutics Inc   17.48 
Corvus Pharmaceuticals Inc   17.45 
Achillion Pharmaceuticals Inc  17.32 
Enanta Pharmaceuticals Inc   16.87 
China Yct International Group, Inc.  16.18 
Cymabay Therapeutics Inc   16.01 
Tricida Inc   15.48 
Anaptysbio inc  15.46 
Inspire Medical Systems inc   15.43 
Ngm Biopharmaceuticals Inc  15.27 
Magenta Therapeutics Inc   15.15 
Global Blood Therapeutics Inc   14.99 
Xenon Pharmaceuticals Inc   14.98 
Albireo Pharma Inc   13.86 
Sage Therapeutics Inc   13.86 
Adial Pharmaceuticals Inc   13.84 
Rocket Pharmaceuticals Inc   13.73 
Hoth Therapeutics Inc   13.68 
Galmed Pharmaceuticals Ltd   13.66 
Nektar Therapeutics  13.45 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RCL's Profile

Stock Price

RCL's Financials

Business Description

Fundamentals

Charts & Quotes

RCL's News

Suppliers

RCL's Competitors

Customers & Markets

Economic Indicators

RCL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071